GSK3β is proposed to activate VDAC1 phosphorylation, ultimately leading to mitochondrial dysfunction and synaptic damage in AD, (iv) Defective mitophagy, (v) increased mitochondrial fission and decreased mitochondrial fusion. This evidence concerns the gene GSK3B and Alzheimer disease.